Table 1:
Study Characteristics
| Authors | Year | Country in which Study was Conducted | Study Design (Level of Evidence) | Number of Patients | Number of Knees | % Female | Age (years) | Follow-Up Time (months) |
|---|---|---|---|---|---|---|---|---|
| Aperture Fixation | ||||||||
| Cavaignac et al. | 2017 | Switzerland | Cohort Study (III) | 45 | 45 | 45% | 32.1 +/− 8 | 3.4 +/− 0.6 |
| Geib et al. | 2009 | United States of America | Retrospective Case Series (IV) | 41 | 41 | 46.3 | NR | 40.5 |
| Gorschewsky et al. | 2007 | Switzerland | Prospective Cohort Study (III) | 124 | 124 | NR | NR | 24 |
| Han et al. | 2008 | South Korea | Therapeutic Study (III) | 72 | 72 | 5.56% | 27.8 (15–51) | 39.7 (24–90) |
| Joseph et al. | 2006 | United States of America | Prospective Comparative Study (II) | 18 | 18 | NR | NR | NR |
| Kim et al. | 2009 | South Korea | Therapeutic Study (III) | 29 | 29 | 62.10% | 25.3 (20–39) | 24 |
| Kim et al. | 2009 | South Korea | Retrospective Comparative Study (III) | 21 | 21 | 14.30% | 27.1 (18–48) | 25.8 (24–37) |
| Kim et al. | 2009 | South Korea | Retrospective Cohort Study (III) | 21 | 21 | 14.30% | 27.1 +/− 9.94 (18–48) | 25.8 +/− 4.4 (24–37) |
| Kwak et al. | 2018 | Korea | Retrospective Cohort Study (III) | 45 | 45 | 15.60% | 34.5 +/− 12.8 | 29.8 +/−0 6.5 (24.9–44.3) |
| Lee et al. | 2007 | South Korea | “Diagnostic Study of Nonconsecutive patients without consistently applied reference gold standard” (III) | 137 | 137 | 10.20% | 27 (16–51) | 59 (37–73) |
| Lee et al. | 2007 | South Korea | Prospective Cohort Study (III) | 247 | 247 | 11.30% | 29 (16–58) | 44 (25–87) |
| Lee et al. | 2016 | South Korea | Cohort Study (III) | 48 | 48 | 8.30% | 31.12 (17–57) | 35.6 (24–61) |
| Lee et al. | 2004 | South Korea | Case Series (IV) | 67 | 67 | 13.40% | 28 (18–51) | 41 (27–49) |
| Lund et al. | 2014 | Denmark | Randomized Control Trial (II) | 26 | 26 | 16% | 30 +/− 9 | |
| Sofu et al. | 2013 | Turkey | Retrospective Cohort Study (III) | 23 | 23 | 8.70% | 26.8 | 37.6 (8–70) |
| Theut et al. | 2003 | United States of America | Prospective Case Series (IV) | 68 | 68 | 57.4 | 31 (15–46) | 20 (12–29) |
| Suspensory Fixation | ||||||||
| Chen et al. | 1999 | Taiwan | Prospective Case Series (IV) | 12 | 12 | 33.30% | 26 (20–39) | 18 (15–24) |
| Chen et al. | 2006 | South Korea | Therapeutic Study (III) | 34 | 34 | 35.30% | 26 (20–59) | 62 (48–84) |
| Guimaraes et al. | 2009 | Brazil | Prospective Cohort Study (III) | 17 | 17 | 11.80% | 28.53 | 10 years |
| Iriuchishima et al. | 2017 | Japan | Prospective Case Series (IV) | 20 | 20 | 90 | 49 | 12 |
| Runer et al. | 2018 | Austria | Prospective Cohort Study (III) | 40 | 40 | 42.50% | 34.6 +/− 11.0 | 6, 12, and 24 |